Comparison of Optimal Hypertension Regimens
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 940 participants.
Also called NCT02847338
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 940 participants
- Sponsor
- Registry
-
NCT02847338
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02847338. Randomized; no masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2023-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Optimal Hypertension Regimens
- Acronym
- AIMHY-INFORM
- Condition
- Hypertension
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Lisinopril
- Intervention (Drug)
- Amiloride
- Intervention (Drug)
- Chlortalidone
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Collaborator
- Medical Research Council
Record details
- Record id
cardio:ct-nct02847338- Content hash
8edadee80592fb36a7ed26c307fd048f4faa0b3d291f49c2e5be7ffdf3368a7f